Minnesota vs Michigan Cannabis Laws

Minnesota legalized recreational cannabis through legislative action in May 2023, passing one of the most comprehensive cannabis reform bills in US history. The law not only permits adult-use sales but includes automatic expungement of prior cannabis convictions, robust social equity provisions, and a detailed regulatory framework. The state's medical cannabis program had been operational since 2014 but was one of the more restrictive in the nation, originally prohibiting smokable flower.

The recreational market has been in the licensing and regulatory build-out phase, with retail sales expected to launch in early 2025. Minnesota's population of 5.7 million and the Minneapolis-St. Paul metropolitan area's economic strength provide a solid foundation for market development. The state has imposed a 10% gross receipts tax, which is relatively moderate and should support legal market competitiveness.

Green Thumb Industries and Verano have established footholds in Minnesota through the medical program. As the recreational market launches, additional MSOs are expected to seek entry. The market's growth trajectory will depend heavily on the speed and efficiency of the state's licensing process and the number of local municipalities that opt to allow cannabis retail operations.

Michigan has emerged as one of the largest cannabis markets in the United States, with annual sales reaching approximately $3 billion at peak. Voters approved medical cannabis in 2008 through Proposition 1, and recreational legalization followed with Proposal 1 in November 2018. Recreational sales began in December 2019, and the market scaled rapidly due to Michigan's large population of 10 million and an open licensing framework.

The Michigan market is notable for its lack of license caps, which has led to a proliferation of retail locations and cultivation facilities. While this openness has benefited consumer access and driven down prices, it has also created significant oversupply challenges. Wholesale flower prices have declined dramatically, squeezing margins for cultivators and putting financial pressure on operators at every level of the supply chain. The state's caregiver system — which allows individuals to grow and supply cannabis to medical patients — adds additional supply outside the commercial market.

Despite the competitive pressures, Michigan remains a priority market for major MSOs including Curaleaf, Green Thumb Industries, Trulieve, Cresco Labs, Verano, TerrAscend, and Ayr Wellness. The 10% excise tax plus 6% sales tax keeps the combined rate moderate at 16%. Michigan's market dynamics serve as a cautionary example of how open licensing can lead to oversupply, but the state's large consumer base ensures it remains commercially significant.